FDA approves Revelation Biosciences’ drug trial for CKD By Investing.com
SAN DIEGO - Revelation Biosciences Inc. (NASDAQ: REVB), a clinical-stage life sciences firm with a market capitalization of $3.26 million, ...
Tag: CKD
SAN DIEGO - Revelation Biosciences Inc. (NASDAQ: REVB), a clinical-stage life sciences firm with a market capitalization of $3.26 million, ...